Results 21 to 30 of about 76,161 (283)

Reverse cardiac remodeling in patients undergoing combination therapy of transcatheter mitral valve repair

Frontiers in Cardiovascular Medicine, 2023
AimsFor patients with severe mitral valve regurgitation (MR), different kinds of transcatheter mitral valve repair (TMVr) exist, targeting the leaflets, annulus, and chordae.
Hiroaki Yokoyama, Tobias Friedrich Ruf, Martin Geyer, Alexander R. Tamm, Jaqueline Grace Da Rocha E Silva, Theresa Ann Maria Gößler, Julia Zirbs, Ben Schwidtal, Thomas Münzel, Ralph Stephan von Bardeleben   +9 more
doaj   +1 more source

Transcatheter and Doppler waveform correlation in transcatheter aortic valve replacement [PDF]

Open Heart, 2018
Transcatheter aortic valve replacement (TAVR) has become the preferred therapy for treatment of severe aortic stenosis in patients at intermediate to high risk of perioperative mortality following surgical aortic valve replacement. Haemodynamic assessment is an integral part of the procedure, and it is crucial for the operator to have an in-depth ...
Ankur Kalra, Raj R Makkar, Deepak L Bhatt, Sahil Khera, Neal S Kleiman, Michael J Reardon, Morton J Kern   +6 more
openaire   +4 more sources

MitraClip and left ventricular reverse remodelling: a strain imaging study

ESC Heart Failure, 2020
Aims The purpose of this study is to identify echocardiography predictors of clinical response and reverse left ventricular (LV) remodelling in patients with functional mitral regurgitation (FMR) treated with MitraClip.
Konstantinos Papadopoulos, Ignatios Ikonomidis, Michael Chrissoheris, Antonios Chalapas, Panagiota Kourkoveli, John Parissis, Konstantinos Spargias   +6 more
doaj   +1 more source

Single‐Center Experience of Hybrid Pulmonary Valve Replacement Using Left Anterior Thoracotomy With Pulmonary Artery Plication in Patients With Large Right Ventricular Outflow Tract

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Until recently, a large right ventricle outflow tract interfered with the feasibility of standard transcatheter pulmonary valve replacement (PVR).
Kaitlin Carr, Bassel Mohammad Nijres, Jimmy J. Windsor, Yuki Nakamura, Mohsen Karimi, Marco Ricci, Osamah Aldoss   +6 more
doaj   +1 more source

Tricuspid Leaflet Gap-Reduction Maneuvers During Transcatheter Tricuspid Valve Repair

JACC: Case Reports, 2023
Transcatheter tricuspid valve edge-to-edge repair (T-TEER) has emerged as an option for treating patients with tricuspid regurgitation. Few studies have explored intraprocedural maneuvers to optimize leaflet-grasping T-TEER in order to improve technical ...
Carlos Godoy Rivas, MD, Vratika Agarwal, MD, Stephen Tomlinson, MBBS, Mark Lebehn, MD, Susheel Kodali, MD, Rebecca T. Hahn, MD   +5 more
doaj   +1 more source

Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)- systematic review and meta-analysis [PDF]

, 2014
The hypothesis of this study was that local anesthesia with monitored anesthesia care (MAC) is not harmful in comparison to general anesthesia (GA) for patients undergoing Transcatheter Aortic Valve Implantation (TAVR).TAVR is a rapidly spreading ...
Webb, J, Reinthaler, M, Georg M Fröhlich, Marco Roffi, Olaf Wendler, Nevil Hutchinson, Markus Reinthaler, Duolao Wang, David Hildick-Smith, Wang, D, Hutchinson, N, Fröhlich, GM, John Webb, Pascal Meier, Alexandra J Lansky, Wendler, O, Hildick-Smith, D, Stefan Toggweiler, Lansky, AJ, Roffi, M, Meier, P, Toggweiler, S   +21 more
core   +1 more source

India’s first transcatheter mitral valve implantation: Mitral valve-in-valve via transapical approach

IHJ Cardiovascular Case Reports, 2018
Valve-in-valve implantation for dysfunctional bioprosthetic valves has been shown to be a safe and feasible option for selected patients (Dvir et al., 2014, Bapat et al., 2012, Piazza et al., 2011).
A.B. Gopalamurugan, Y. Vijaya Chandra Reddy, R. Mohamed Abubacker, D. Karthikeyan, S. Vijay Shankar   +4 more
doaj   +1 more source

Possible effect of direct oral anti-coagulant for preventing long stenting lesion from in-stent restenosis in femoropopliteal segment: Case report with angioscopy findings

SAGE Open Medical Case Reports, 2020
A 64-year-old female underwent a successful first percutaneous intervention using MISAGO stents for a de novo femoropopliteal lesion. Subsequently, three more effective procedures were done using balloon catheters for in-stent restenosis.
Taketsugu Tsuchiya, Satori Akita, Minako Oda, Takaaki Takamura, Katsuhide Kitagawa, Koji Kajinami, Michihiko Kitayama   +6 more
doaj   +1 more source

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]

, 2012
BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R, Dewey, Todd M, Pocock, Stuart, Brown, David L, Pichard, Augusto D, Bowers, Bruce, Siegel, Robert J, Smith, Craig R, Webb, John G, Tuzcu, Murat, Moses, Jeffrey W, Williams, Matthew R, Babaliaros, Vasilis C, Thourani, Vinod H, Kapadia, Samir, Svensson, Lars G, Jilaihawi, Hasan, Kodali, Susheel, Bavaria, Joseph E, MD, Fontana, Gregory P, Akin, Jodi J, Douglas, Pamela S, Bavaria, Joseph E, Herrmann, Howard C, Leon, Martin B, PARTNER Trial Investigators, Anderson, William N   +26 more
core   +1 more source

India’s first percutaneous tricuspid valve implantation: Valve-in-valve is a treatment option for bioprosthetic valve dysfunction

IHJ Cardiovascular Case Reports, 2017
Bioprosthetic valve dysfunction leading to haemodynamically significant consequences is well recognised. Traditional treatment of choice has been conventional re-do surgical valve replacement. However, over the last decade, percutaneous solutions such as
A.B. Gopalamurugan, R. Mohamed Abubacker, Prashant Vaijyanath   +2 more
doaj   +1 more source